Home/Filings/4/0001844320-25-000007
4//SEC Filing

Schlosser Mario 4

Accession 0001844320-25-000007

CIK 0001568651other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 4:18 PM ET

Size

28.6 KB

Accession

0001844320-25-000007

Insider Transaction Report

Form 4
Period: 2025-11-11
Schlosser Mario
DirectorPresident of Technology & CTO
Transactions
  • Conversion

    Class A Common Stock

    2025-11-11+286,182787,330 total
  • Sale

    Class A Common Stock

    2025-11-12$15.05/sh105,300$1,584,765501,148 total
  • Exercise/Conversion

    Class B Common Stock

    2025-11-11$6.36/sh+413,835$2,631,9911,929,138 total
    Class A Common Stock (413,835 underlying)
  • Conversion

    Class B Common Stock

    2025-11-11286,1821,642,956 total
    Class A Common Stock (286,182 underlying)
  • Conversion

    Class A Common Stock

    2025-11-12+105,300606,448 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-11-12141,3300 total
    Exercise: $6.36Exp: 2025-12-07Class B Common Stock (141,330 underlying)
  • Exercise/Conversion

    Class B Common Stock

    2025-11-12$6.36/sh+141,330$898,8591,784,286 total
    Class A Common Stock (141,330 underlying)
  • Conversion

    Class B Common Stock

    2025-11-12105,3001,678,986 total
    Class A Common Stock (105,300 underlying)
  • Sale

    Class A Common Stock

    2025-11-11$15.27/sh286,182$4,369,999501,148 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-11-11413,835141,330 total
    Exercise: $6.36Exp: 2025-12-07Class B Common Stock (413,835 underlying)
Holdings
  • Class B Common Stock

    (indirect: By Trust)
    Class A Common Stock (333,333 underlying)
    333,333
  • Class B Common Stock

    (indirect: By Trust)
    Class A Common Stock (633,333 underlying)
    633,333
  • Class B Common Stock

    (indirect: By Trust)
    Class A Common Stock (333,333 underlying)
    333,333
Footnotes (6)
  • [F1]The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.
  • [F2]The sale was effected to cover the cost of exercise and to satisfy the Reporting Person's tax withholding obligation arising from the stock option exercise reported herein.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.83 to $15.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  • [F5]The stock option is fully vested and exercisable, and expires on December 7, 2025.
  • [F6]Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any.

Issuer

Oscar Health, Inc.

CIK 0001568651

Entity typeother

Related Parties

1
  • filerCIK 0001844320

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:18 PM ET
Size
28.6 KB